The ECEL1 Knockout HEK293T Polyclonal Cells are a ready-to-use CRISPR/Cas9-edited polyclonal knockout cell population designed for functional investigation of endothelin-converting enzyme-like 1 (ECEL1). This product comprises a pool of HEK293T cells carrying targeted disruption of the ECEL1 gene, providing a robust loss-of-function model without clonal isolation. The polyclonal format preserves population-level heterogeneity while ensuring broad knockout representation, suitable for high-throughput screening and biochemical analyses.
The host cell line, HEK293T, is a widely employed human embryonic kidney epithelial derivative that stably expresses the SV40 large T-antigen. This genetic background enhances episomal replication of plasmids containing the SV40 origin, enabling high-level transient protein production and efficient generation of retroviral and lentiviral particles. HEK293T cells are a cornerstone model for functional genomics, protein biochemistry, and pharmacological screening due to their rapid growth and ease of transfection.
ECEL1 encodes a type II integral membrane metalloprotease that functions within the secretory pathway to process bioactive neuropeptides. It is transcriptionally regulated by neurogenic factors such as NEUROD and ASCL1, acting downstream of Notch signaling during neuronal differentiation. ECEL1 cleaves pro-neuropeptides including substance P and neurotensin, generating mature ligands that activate cognate neurokinin receptors. This processing event is critical for proper neuromuscular junction assembly, collaborating with the Agrin?CMuSK?CLRP4 signaling axis. Intracellularly, ECEL1 interacts with ER-resident chaperones like calnexin to ensure proper folding and trafficking, linking post-translational modification to neuropeptide signaling.
In the HEK293T context, introduction of ECEL1 disruption permits dissection of metalloprotease-substrate interactions in a simplified, non-neuronal cellular environment. The knockout model circumvents the complexity of primary neurons, enabling biochemical reconstitution of neuropeptide maturation pathways. This system is particularly advantageous for studying protein processing in the early secretory pathway, as HEK293T cells already support robust ER?CGolgi trafficking. Researchers can express exogenous substrates and monitor cleavage events in the absence of endogenous ECEL1 activity, facilitating identification of direct versus indirect processing events.
Key applications include elucidation of ECEL1 substrate repertoires via mass spectrometry?Cbased peptidomics, screening of small-molecule protease inhibitors, and functional complementation assays to validate candidate substrates. The model supports investigation of neuromuscular junction signaling through co-culture paradigms and enables assessment of neuropeptide-dependent cellular responses. Typical assays encompass western blotting for ECEL1, RT-qPCR validation of knockout efficiency, immunofluorescence for synaptic marker expression, and neuropeptide cleavage activity measurements. For detailed inquiries and technical support, please contact Ascent Research.
